Citadel Advisors’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-73,800
Closed -$114K 15239
2021
Q4
$114K Sell
73,800
-32,700
-31% -$53.9K ﹤0.01% 12592
2021
Q3
$167K Sell
106,500
-11,600
-10% -$22.7K ﹤0.01% 12234
2021
Q2
$311K Buy
118,100
+58,500
+98% +$109K ﹤0.01% 11179
2021
Q1
$90K Sell
59,600
-8,900
-13% -$15.4K ﹤0.01% 12564
2020
Q4
$89K Sell
68,500
-110,200
-62% -$124K ﹤0.01% 10291
2020
Q3
$202K Buy
178,700
+85,300
+91% +$93.8K ﹤0.01% 8786
2020
Q2
$78K Buy
93,400
+79,700
+582% +$59.2K ﹤0.01% 9122
2020
Q1
$10K Buy
+13,700
New +$15.3K ﹤0.01% 9429
2019
Q2
Sell
-10,400
Closed -$39K 10135
2019
Q1
$39K Sell
10,400
-4,800
-32% -$15.2K ﹤0.01% 8916
2018
Q4
$33K Sell
15,200
-2,700
-15% -$6.7K ﹤0.01% 8597
2018
Q3
$48K Buy
+17,900
New +$63.2K ﹤0.01% 8816
2018
Q2
Sell
-15,200
Closed -$55K 9467
2018
Q1
$55K Sell
15,200
-900
-6% -$3.34K ﹤0.01% 7907
2017
Q4
$60K Buy
+16,100
New +$64.5K ﹤0.01% 7580
2016
Q3
Sell
-11,200
Closed -$44K 7970
2016
Q2
$44K Buy
+11,200
New +$43.9K ﹤0.01% 6440
2016
Q1
Sell
-5,300
Closed -$23K 8394
2015
Q4
$23K Sell
5,300
-11,800
-69% -$50.7K ﹤0.01% 7844
2015
Q3
$72K Buy
17,100
+1,700
+11% +$10.7K ﹤0.01% 7281
2015
Q2
$125K Buy
15,400
+5,400
+54% +$45K ﹤0.01% 6858
2015
Q1
$78K Sell
10,000
-7,800
-44% -$66.7K ﹤0.01% 7057
2014
Q4
$208K Sell
17,800
-16,300
-48% -$195K ﹤0.01% 5941
2014
Q3
$441K Buy
34,100
+4,600
+16% +$60.7K ﹤0.01% 4783
2014
Q2
$448K Buy
+29,500
New +$479K ﹤0.01% 4547

Citadel Advisors's CSLT Position: Q1 2022 in Review

Citadel Advisors sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 213,778 shares — an estimated $329K sold.

Citadel Advisors first reported a position in CSLT in Q2 2014 and held it in 29 quarters. The position peaked at $1.36M in Q3 2015. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • Citadel Advisors reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 213,778 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $329K.
  • Citadel Advisors first reported a position in CASTLIGHT HEALTH, INC. in Q2 2014 and held it in 29 quarters.
  • Citadel Advisors's CASTLIGHT HEALTH, INC. position peaked at $1.36M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.